Table 7

Probabilistic sensitivity analysis for HAPO (4) in a population with NICE risk factors

Diagnostic thresholdNMB*
CE threshold £30 000 per QALY
Probability cost-effective
CE threshold £20 000 per QALY (%)
Probability cost-effective
CE threshold WTP=£30 000 per QALY (%)
No treatment£054.121.0
NICE 2015£239 90243.351.5
WHO 2013£186 6752.727.6
  • *NMB is measured relative to a baseline of no treatment

  • CE, cost-effectiveness; HAPO, Hyperglycaemia and Adverse Pregnancy Outcomes; NICE, National Institute for Health and Care Excellence; NMB, net monetary benefit; QALY, quality-adjusted life year; WTP, willingness to pay.